Company research / AHCO

AdaptHealth Corp. (AHCO)

CIK 0001725255 · Nasdaq · Services-Home Health Care Services

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, AdaptHealth Corp. reported revenue of $3.24B. Revenue fell 0.5% from the prior annual period.

Key ratios (year ended 2025-12-31)

18.8%
Gross margin (computed)
2.8%
Operating margin
-2.2%
Net margin
-4.7%
Return on year-end equity
-0.5%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-11

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312020-09-302020-06-302020-03-312019-12-31
Revenuen/a$3.24B$3.26B$3.20B$2.97B$2.45B$1.06Bn/an/an/a$529.64M
Cost of Revenuen/a$2.64B$2.58B$2.58B$2.39B$2.01B$898.60Mn/an/an/a$440.70M
Gross Profit (computed)n/a$609.20M$681.09M$624.07M$580.12M$445.61M$157.79Mn/an/an/a$88.94M
Operating Incomen/a$90.87M$263.73M-$598.40M$190.41M$225.60M$71.35Mn/an/an/a$29.38M
Depreciation & Amortization$421.99M$381.93M$365.33M$382.78M$351.18M$258.05M$82.44Mn/an/an/a$62.57M
EBITDAn/a$472.80M$629.07M-$215.62M$541.59M$483.66M$153.79Mn/an/an/a$91.94M
Net Income-$228.23M-$70.79M$90.42M-$678.89M$69.32M$156.18M-$161.63Mn/an/an/a-$21.34M
EPS (Diluted)n/a-$0.52$0.61-$5.31$0.33$0.67-$3.08n/an/an/a-$0.95
Total Assets$4.34B$4.32B$4.49B$4.51B$5.22B$5.25B$1.81B$1.56B$742.47M$665.00M$546.54M
Total Liabilities$2.95B$2.79B$2.91B$3.04B$3.06B$3.18B$1.53B$1.21B$813.81M$765.43M$612.32M
Long-Term Debt$1.89B$1.74B$1.98B$2.15B$2.19B$2.20B$784.71Mn/an/an/a$396.83M
Shareholders' Equity$1.38B$1.52B$1.57B$1.46B$2.15B$2.06B$354.89M$361.00M-$58.67M-$54.08M-$38.82M
Operating Cash Flow$583.27M$601.77M$541.84M$480.67M$373.87M$275.68M$195.63Mn/an/an/a$60.42M
Capital Expenditures$485.59M$382.39M$306.06M$337.46M$391.42M$203.31M$39.76Mn/an/an/a$21.33M
Free Cash Flow$97.68M$219.38M$235.78M$143.20M-$17.56M$72.37M$155.88Mn/an/an/a$39.09M
Share Repurchasesn/a$0$0$29.27M$13.99M$0$0n/an/an/a$20.00M
Shares Outstanding136.31M135.45M134.60M132.63M134.44M133.84Mn/an/an/an/an/a
Weighted Average Diluted Sharesn/a135.15M135.53M134.42M138.99M133.03M52.49Mn/an/an/a22.56M
EPS (Basic)n/a-$0.52$0.62-$5.06$0.47$1.12-$3.08n/an/an/a-$0.95

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView